Velcheti, V., Hu, X., Piperdi, B., & Burke, T. (2021). Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices. Sci Rep.
Citação norma ChicagoVelcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, and Thomas Burke. "Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC At US Oncology Practices." Sci Rep 2021.
MLA引文Velcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, and Thomas Burke. "Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC At US Oncology Practices." Sci Rep 2021.
警告：這些引文格式不一定是100％准確.